viral
respiratori
infect
may
associ
virusinduc
asthma
adult
well
children
particularli
human
rhinoviru
strongli
suggest
major
candid
associ
virusinduc
asthmathu
review
review
focus
epidemiolog
pathophysiolog
treatment
virusinduc
asthma
special
refer
human
rhinoviru
furthermor
ad
preliminari
data
regard
clinic
virolog
find
present
review
takizawa
h
epidemiolog
virusinduc
asthma
exacerb
special
refer
role
human
rhinoviru
front
microbiol
differ
type
virus
human
rhinoviru
hrv
human
metapneumoviru
hmpv
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
hpiv
known
caus
acut
respiratori
ill
ari
tsukagoshi
et
al
recent
report
issu
virusinduc
exacerb
asthma
chronic
obstruct
pulmonari
diseas
kurai
et
al
howev
among
caus
virus
hrv
recogn
major
impact
asthma
pathogenesi
fujitsuka
et
al
perspect
review
literatur
regard
epidemiolog
hrvinduc
asthma
adult
togeth
preliminari
epidemiolog
data
obtain
institut
hrv
belong
genu
enteroviru
famili
picornavirida
turner
couch
hrv
possess
singl
strand
positivesens
rna
ssrna
genom
approxim
kb
viral
capsid
compos
four
viral
protein
assembl
protom
result
small
icosahedr
structur
diamet
nm
turner
couch
genet
hrv
classifi
three
speci
hrva
b
c
simmond
et
al
furthermor
speci
hrv
genotyp
andri
et
al
arakawa
et
al
kiyota
et
al
kiyota
et
al
molecular
epidemiolog
studi
suggest
domin
speci
hrva
c
hrvb
rel
rare
detect
arakawa
et
al
kiyota
et
al
particular
protein
variat
amino
acid
sequenc
account
larg
number
viral
serotyp
turner
couch
host
receptor
hrv
respiratori
epitheli
cell
intracellular
adhes
molecul
major
hrv
serotyp
hrva
b
lowdens
lipoprotein
receptor
ldlr
minor
hrv
serotyp
receptor
hrvc
yet
known
suggest
optim
temperatur
replic
hrv
rel
cool
c
would
limit
infect
upper
airway
howev
larg
medium
size
airway
lower
respiratori
tract
also
consid
cool
enough
hrv
replic
spite
higher
temperatur
lung
parenchyma
c
mcfadden
et
al
therefor
hrv
potenti
caus
agent
sever
ari
bronchiol
pneumonia
turner
couch
watanab
et
al
smut
et
al
arakawa
et
al
may
associ
virusinduc
asthma
linsuwanon
et
al
fujitsuka
et
al
smut
et
al
hrv
might
therefor
involv
variou
ari
addit
respiratori
complic
kiyota
et
al
lieberman
et
al
report
detect
viru
includ
hrv
sensit
rate
nasopharyng
swab
superior
oropharyng
swab
respect
common
cold
third
common
primari
diagnosi
offic
visit
hsiao
et
al
diseas
gener
selflimit
usual
last
day
fashner
et
al
among
gener
popul
hrv
infect
caus
common
cold
frequenc
makela
et
al
van
gageldonklafeb
et
al
tyrrel
et
al
report
intranas
wwwfrontiersinorg
inocul
either
hrv
serotyp
coronaviru
type
rsv
healthi
volunt
induc
pattern
symptom
develop
substanti
differ
howev
individu
sign
symptom
occur
earliest
hrv
infect
coronaviru
lastli
rsv
appear
day
inocul
demonstr
long
incub
period
rsv
volunt
tyrrel
et
al
hrv
implic
patient
acut
otiti
media
exacerb
chronic
obstruct
pulmonari
diseas
common
cold
lower
respiratori
tract
infect
neonat
elderli
immunocompromis
arruda
et
al
research
frequenc
natur
histori
hrv
infect
adult
autumn
demonstr
first
symptom
notic
often
sore
throat
hrv
cultureor
pcrposit
patient
stuffi
nose
hrvneg
patient
use
nasal
wash
specimen
respiratori
symptom
typic
develop
day
inocul
studi
uncompl
hrv
infect
usual
peak
day
inocul
median
durat
hrv
cold
week
last
week
gwaltney
et
al
rotbart
hayden
note
ill
caus
hrv
viral
shed
occur
natur
day
predominantli
day
period
hrva
major
group
viru
commonli
use
experiment
human
infect
hrva
use
anim
model
hrv
infect
close
relat
grunberg
et
al
report
experiment
infect
via
nasal
inhal
lead
transient
decreas
fev
patient
asthma
decreas
lung
function
correl
enhanc
cold
symptom
airway
hyperrespons
contoli
et
al
demonstr
type
iii
interferon
product
level
ex
vivo
cell
cultur
deriv
bronchial
epitheli
cell
bec
macrophag
obtain
asthmat
patient
lower
deriv
healthi
control
furthermor
defici
product
correl
hrv
viral
load
sever
clinic
symptom
fev
messag
et
al
demonstr
sever
intranas
inocul
hrvinduc
clinic
ill
asthmat
subject
correl
viru
load
lower
airway
virusinduc
inflamm
hand
demor
et
al
report
differ
clinic
symptom
pattern
viral
shed
note
subject
persist
allerg
asthma
healthi
subject
experiment
infect
hrv
differ
result
experiment
hrv
infect
individu
studi
asthmat
patient
healthi
subject
might
depend
sever
asthma
subject
enrol
studi
inde
sever
report
neither
defect
ifn
induct
hrv
increas
hrv
replic
observ
primari
human
bec
deriv
subject
well
control
asthma
lopezsouza
et
al
bochkov
et
al
syke
et
al
anim
model
rhinoviru
infect
show
major
group
hrv
ie
bind
mous
minor
group
hrv
ie
infect
mous
regard
bartlett
et
al
gener
transgen
balbc
mous
express
mousehuman
chimer
receptor
infect
studi
also
show
asthma
exacerb
model
intraperiton
sensit
ovalbumin
aluminum
hydroxid
follow
intranas
inocul
uvinactiv
although
data
regard
viru
respiratori
infect
vri
precipit
asthma
attack
adult
less
clear
nicholson
et
al
report
vri
commonli
link
exacerb
adult
children
johnston
et
al
fujitsuka
et
al
studi
show
virus
detect
clinic
exacerb
episod
decreas
peak
expiratori
flow
rate
pefr
mlminut
commonli
identifi
viru
hrv
follow
coronavirus
parainfluenza
virus
nicholson
et
al
thu
viru
commonli
detect
asthma
exacerb
appear
hrv
although
hrv
well
known
frequent
caus
common
cold
implic
hrv
infect
vari
accord
respiratori
diseas
tabl
show
frequenc
hrv
infect
variou
adult
respiratori
diseas
exacerb
asthma
nicholson
et
al
atmar
et
al
tan
et
al
common
cold
makela
et
al
van
gageldonklafeb
et
al
exacerb
copd
seemung
et
al
rohd
et
al
tan
et
al
beckham
et
al
papi
et
al
hutchinson
et
al
ko
et
al
mcmanu
et
al
kherad
et
al
dimopoulo
et
al
perotin
et
al
commun
acquir
pneumonia
jen
et
al
johnston
et
al
johansson
et
al
lieberman
et
al
fri
et
al
wootton
et
al
luchsing
et
al
takahashi
et
al
huijsken
et
al
exacerb
idiopath
pulmonari
fibrosi
wootton
et
al
asymptomat
infect
fri
et
al
risk
exacerb
asthma
adult
elev
children
return
school
around
decemb
christma
holiday
western
countri
like
due
social
interact
children
time
prospect
monitor
studi
use
revers
transcript
polymeras
chain
reaction
rtpcr
indic
mani
acut
asthma
exacerb
children
adult
associ
presenc
upper
respiratori
tract
urt
infect
corn
et
al
found
detect
rate
hrv
asthmat
healthi
particip
similar
lrt
symptom
significantli
sever
longer
last
asthmat
group
healthi
group
base
one
definit
urt
lrt
symptom
tabl
johnston
et
al
common
antigen
across
strain
hrv
therefor
reliabl
diagnost
method
hrv
infect
establish
use
hrv
antigen
hrvspecif
antibodi
although
viral
cultur
convent
method
hrv
detect
cultur
method
practic
clinic
set
detect
hrv
slow
grow
charact
requir
specif
cultur
condit
furthermor
diagnost
capabl
molecular
amplif
techniqu
frontier
microbiolog
virolog
exacerb
asthma
nicholson
et
al
tan
et
al
atmar
et
al
common
cold
makela
et
al
cite
adapt
johnston
et
al
nucleic
acid
sequencebas
amplif
rtpcr
superior
cultur
method
loen
et
al
experiment
hrv
infect
shown
lead
longlast
excess
airway
narrow
volunt
subject
asthma
cheung
et
al
grunberg
et
al
note
rhinoviru
unlik
influenza
virus
caus
minim
cytotox
fraenkel
et
al
amount
epitheli
damag
correl
sever
symptom
hrv
infect
caus
addit
synergist
effect
exacerb
asthma
via
influx
addit
inflammatori
cell
airway
preexist
inflamm
result
airway
cholinerg
hyperrespons
nagarkar
et
al
allerg
respons
effect
hrv
infect
enhanc
contractil
airway
smooth
muscl
asm
cell
impair
relax
cholinerg
agonist
attribut
sole
bind
viru
host
receptor
asm
cell
surfac
proasthmaticlik
effect
recogn
even
situat
complet
inhibit
viral
replic
vitro
set
pretreat
asm
neutral
antibodi
direct
grunstein
et
al
thu
hrv
attach
affect
contractil
asm
cell
absenc
cytopath
effect
chun
et
al
report
cell
infect
hrv
vitro
produc
higher
valu
rant
rsv
adenoviru
addit
combin
hrv
der
hous
dust
mite
antigen
act
synergist
induc
product
find
reason
hrv
major
pathogen
acut
exacerb
asthma
present
schema
pathogenesi
hrv
associ
asthma
exacerb
figur
requir
follow
step
hrv
attach
airway
epitheli
cell
innat
immun
respons
lead
epitheli
damag
infectionrel
airway
remodel
rtpcr
use
either
supplement
replac
convent
cultur
techniqu
virus
found
approxim
one
half
three
quarter
adult
experienc
acut
wheez
episod
jackson
johnston
major
virus
identifi
hrv
nicholson
et
al
howev
evid
weak
mechan
poorli
understood
initi
hrva
b
attach
airway
epitheli
cell
via
ldlr
kennedi
et
al
receptor
receptor
recent
identifi
group
hrvc
yet
clarifi
hrvinfect
bec
secret
wide
rang
cytokin
chemokin
regul
activ
normal
cell
express
secret
gmcsf
protein
jackson
johnston
proud
induc
neutrophil
lymphocyt
eosinophil
inflamm
togeth
airway
hyperrespons
airway
remodel
wark
et
al
proud
clearanc
viral
pathogen
begin
interferon
secret
underproduct
factor
postul
lead
viralinduc
exacerb
three
type
interferon
base
receptor
bind
type
type
ii
wwwfrontiersinorg
type
iii
hrv
infect
induc
epitheli
express
mrna
type
type
iii
ifn
suggest
impair
epitheli
product
asthmat
subject
may
contribut
viral
exacerb
asthma
wark
et
al
contoli
et
al
contoli
et
al
show
signific
invers
correl
ex
vivo
product
sever
symptom
bronchoalveolar
lavag
viral
load
airway
inflamm
strong
posit
correl
reduct
lung
function
vivo
infect
genomewid
associ
studi
show
singl
nucleotid
polymorph
involv
variou
diseas
polymorph
may
effect
incid
hrv
infect
russel
et
al
messag
et
al
report
viru
load
asthmat
subject
relat
increas
lower
airway
inflamm
turn
increas
lower
airway
inflamm
relat
increas
symptom
reduct
lung
function
increas
bronchial
hyperreact
data
suggest
causal
role
hrv
infect
pathogenesi
asthma
exacerb
investig
virusallergen
interact
durrani
et
al
demonstr
anoth
mechan
increas
express
crosslink
highaffin
ige
receptor
plasmacytoid
dendrit
cell
associ
reduc
hrvinduc
secret
allerg
asthmat
children
significantli
reduc
hrvinduc
product
crosslink
type
induc
nitric
oxid
synthas
ino
major
no
isoform
found
epitheli
cell
gener
substanti
amount
nitric
oxid
molecul
inhibit
replic
hrv
airway
epitheli
cell
suppress
hrvinduc
cytokin
product
proud
although
measur
fraction
concentr
exhal
breath
feno
may
use
support
diagnosi
asthma
dweik
et
al
howev
increas
feno
seem
alway
correl
viral
load
period
hrv
infect
sander
et
al
factor
allergi
allergen
exposur
tobacco
smoke
particul
ozon
stress
infect
sinus
commonli
contribut
exacerb
asthma
graing
et
al
report
repeat
bronchoconstrict
asthma
promot
airway
remodel
clear
evid
airway
remodel
begin
earli
childhood
present
even
clinic
diagnosi
asthma
establish
pohunek
et
al
increas
evid
regard
hrvinduc
wheez
exacerb
asthma
rais
possibl
hrv
infect
could
contribut
initi
subsequ
progress
airway
remodel
involv
multipl
factor
increas
epitheli
releas
activin
amphiregulin
matrix
metalloproteinas
epiderm
growth
factor
egf
fibroblast
growth
factor
fgf
vascular
endotheli
growth
factor
vegf
hrv
infect
upregul
product
epitheli
cell
lead
airflow
obstruct
asthma
hewson
et
al
activin
member
superfamili
amphiregulin
member
egf
famili
alter
repair
process
leigh
et
al
activin
amphiregulin
link
subepitheli
basement
membran
thicken
asthma
appear
import
role
asthma
exacerb
airway
remodel
sampsona
et
al
express
vegf
receptor
increas
asthmat
subject
vegf
major
proangiogen
activ
asthmat
airway
felti
et
al
simcock
et
al
kuga
et
al
report
adult
asthmat
patient
common
cold
suffer
asthma
attack
common
cold
significantli
associ
acut
exacerb
asthma
also
state
hrv
infect
might
import
viru
detect
rtpcr
throat
gargl
kuga
et
al
virusinduc
exacerb
asthma
critic
issu
gener
physician
howev
among
asthmat
patient
exacerb
statu
distinguish
patient
vri
difficult
furthermor
epidemiolog
data
regard
adult
asthma
exacerb
spars
report
investig
preval
vri
exacerb
adult
asthma
hospit
nothospit
patient
character
clinic
radiolog
find
perform
prospect
observ
cohort
studi
conduct
kyorin
univers
hospit
tokyo
japan
august
august
kurai
et
al
patient
respiratori
symptom
associ
exacerb
asthma
includ
sampl
collect
nasopharyng
oropharyng
swab
subject
pcr
method
detect
common
respiratori
virus
patient
enrol
consist
hospit
n
nothospit
patient
n
tabl
two
group
subject
background
similar
age
sex
smoke
rate
durat
ill
howev
measur
valu
spo
significantli
lower
hospit
patient
nonhospit
patient
incid
vri
significantli
higher
former
group
n
latter
group
n
p
latter
group
influenza
viru
alon
detect
patient
furthermor
hospit
patient
n
wheez
sever
exacerb
base
at
american
thorac
societi
er
european
respiratori
societi
statement
reddel
et
al
wherea
among
nonhospit
patient
nine
patient
consid
sever
exacerb
p
patient
wheez
p
find
suggest
viru
infect
certainli
associ
hypoxemia
wheez
result
sever
seriou
asthma
attack
base
japanes
guidelin
ohta
et
al
atser
statement
reddel
et
al
previou
studi
use
ohta
et
al
defin
reddel
et
al
p
p
data
present
mean
sd
pcrbase
viral
diagnost
found
viral
respiratori
infect
detect
exacerb
asthma
children
exacerb
adult
nicholson
et
al
johnston
et
al
similar
result
serum
inflammatori
allerg
marker
differ
hospit
nonhospit
patient
tabl
hospit
patient
virus
identifi
hrv
n
hmpv
n
rsv
n
time
admiss
virusposit
group
n
signific
lower
valu
spo
virusneg
group
n
spo
p
patient
whose
data
avail
frequenc
hypercapnea
paco
torr
significantli
higher
viru
posit
group
n
viru
neg
group
p
tabl
mechan
hypercapnea
viru
infect
individu
elucid
howev
cheung
et
al
report
hrv
infect
caus
long
last
excess
airway
narrow
respons
methacholin
asthmat
subject
specul
smooth
muscl
might
role
exagger
airway
narrow
viru
posit
asthmat
patient
describ
king
et
al
interestingli
incid
ground
glass
opac
ggo
high
resolut
comput
tomographi
seem
higher
virusposit
hospit
patient
virusneg
patient
reach
statist
signific
exampl
figur
show
patchi
ggo
thicken
interlobular
septa
woman
admit
asthma
attack
induc
hrva
figur
also
show
ggo
man
asthma
attack
caus
hrvc
infect
ggo
patient
could
detect
hrct
chest
xray
result
suggest
hrv
major
caus
virusinduc
asthma
possibl
involv
lower
airway
lung
parenchyma
featur
appear
ggo
viral
infect
significantli
exagger
respiratori
statu
low
spo
hypercapnea
compar
virusneg
asthma
exacerb
patient
time
admiss
inde
recent
year
hrv
recogn
common
caus
hospit
admiss
agent
bronchopneumonia
exacerb
chronic
pulmonari
condit
even
elderli
year
age
pierang
et
al
curious
initi
treatment
intraven
steroid
virusposit
neg
group
signific
differ
durat
respiratori
failur
wheez
day
hospit
even
time
requir
steroid
treatment
establish
treatment
prevent
hrvinduc
asthma
avail
describ
exploratori
intervent
follow
inhal
corticosteroid
ic
main
drug
regular
asthma
therapi
ic
treatment
improv
airway
hyperrespons
asthmat
patient
experiment
challeng
hrv
howev
ic
treatment
reduc
accumul
inflammatori
cell
except
eosinophil
bronchial
epithelium
grunberg
et
al
doublestrand
rna
dsrna
viral
product
ligand
tolllik
upregul
express
inflammatori
chemokin
airway
epitheli
cell
matsukura
et
al
report
treatment
cell
fluticason
propion
significantli
dosedepend
inhibit
dsrnainduc
express
protein
mrna
confirm
effect
ssrna
hrv
would
need
studi
leukotrien
receptor
antagonist
prescrib
asthmat
patient
without
ic
montelukast
treatment
improv
asthma
control
cold
symptom
score
hrv
experiment
inocul
mild
asthmat
healthi
subject
kloepfer
et
al
uncertain
whether
leukotrien
receptor
antagonist
treatment
effect
reduct
asthma
symptom
associ
hrv
infect
zambrano
et
al
report
high
serum
ige
level
mildli
asthmat
children
experiment
hrv
infect
may
associ
enhanc
lower
respiratori
symptom
elev
inflammatori
marker
nasal
eosinophil
cation
protein
expir
nitric
oxid
healthi
subject
andor
low
ige
asthmat
patient
preval
asthma
close
associ
serum
ige
level
standard
age
sex
burrow
et
al
airway
hyperrespons
appear
close
link
allerg
diathesi
reflect
serum
total
ige
level
sear
et
al
omalizumab
antiig
monoclon
antibodi
indic
inadequ
control
moderatetosever
persist
allerg
asthma
patient
treat
high
dose
ic
durrani
et
al
show
ige
receptor
invers
associ
secret
plasmacytoid
dendrit
cell
deriv
allerg
asthmat
children
challeng
hrv
omalizumab
downregul
express
dendrit
cell
prussin
et
al
may
reduc
exacerb
asthma
associ
increas
product
ifn
drug
clinic
use
hrv
infect
although
sever
drug
tri
treatment
prevent
hrv
infect
drug
summar
review
jacob
et
al
ifn
potenti
protect
role
viral
induc
asthma
cakebread
et
al
gaajetaan
et
al
becker
et
al
show
exogen
inhibit
hrv
replic
bec
healthi
donor
macrolid
known
possess
antiinflammatori
immunomodulatori
action
extend
beyond
antibacteri
activ
pulmonari
inflammatori
disord
takizawa
et
al
min
jang
erythromycin
inhibit
hrv
infect
reduc
express
surfac
human
tracheal
epitheli
cell
modul
inflamm
suppress
product
proinflammatori
cytokin
suzuki
et
al
yamaya
et
al
report
mucolyt
drug
ambroxol
hydrochlorid
antibiot
drug
levofloxacin
yamaya
et
al
bronchodil
tiotropium
tulobuterol
procaterol
asthma
copd
yamaya
et
al
yamaya
et
al
yamaya
et
al
may
benefici
effect
hrv
infect
inhibit
hrv
replic
partli
reduc
express
acid
endosom
product
via
inhibit
nfkappab
activ
yamaya
review
previou
report
regard
hrvinduc
asthma
exacerb
togeth
result
institut
prospect
studi
hrv
major
pathogen
asthma
exacerb
certainli
associ
seriou
clinic
condit
hypoxemia
hypercapnea
hospit
patient
accumul
evid
virusinduc
asthma
multidisciplinari
assess
would
help
physician
recogn
condit
understand
pathogen
mechan
